Haploidentical Stem Cell Transplantation Using Post-Transplant Cyclophosphamide
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Non-Hodgkin Lymphoma
Related studies linked through entity extraction aliases.
Early FDG PET/CT Imaging as a Measure of Response in Patients With Non-Hodgkin Lymphoma on Lenalidomide
- Status
- TERMINATED
- Phase
- N/A
Umbilical & Cord Blood (CB) Derived CAR-Engineered NK Cells for B Lymphoid Malignancies
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Ph I Trial of NAM NK Cells and IL-2 for Adult Pts With MM and NHL
- Status
- COMPLETED
- Phase
- PHASE1
Biobehavioral Intervention to Enhance Hematopoietic Stem Cell Transplant Recovery
- Status
- COMPLETED
- Phase
- NA
CD30 CAR T Cells, Relapsed CD30 Expressing Lymphoma (RELY-30)
- Status
- RECRUITING
- Phase
- PHASE1
A Study Of Blinatumomab For The Treatment Of Relapsed Or Refractory Indolent Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
Development of a Tissue-Based & Cell Free DNA Next-Generation Sequencing Workflow
- Status
- UNKNOWN
- Phase
- N/A
Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery
- Status
- COMPLETED
- Phase
- N/A
The Lymphoma Epidemiology of Outcomes (LEO) Cohort Study
- Status
- WITHDRAWN
- Phase
- N/A
DS-3201b in Participants With Lymphomas
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Use of EBUS TBNA for Cell Culture as an Aid to Diagnose Lung Cancer and Lymphoma
- Status
- COMPLETED
- Phase
- NA
A Safety Study of SGN-CD19B in Patients With B-cell Non-Hodgkin Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1
Study of ADCT-402 in Patients With Relapsed or Refractory B-cell Lineage Non Hodgkin Lymphoma (B-NHL)
- Status
- COMPLETED
- Phase
- PHASE1
Dosimetry Study of Betalutin for Treatment of Relapsed Non-Hodgkin Lymphoma (LYMRIT-37-02)
- Status
- WITHDRAWN
- Phase
- PHASE1
A Study of Duvelisib and Venetoclax in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia, Small Lymphocytic Lymphoma, or Indolent or Aggressive Non-Hodgkin Lymphoma, Who Have Not Previously Received a Bcl-2 or PI3K Inhibitor
- Status
- WITHDRAWN
- Phase
- PHASE1
Safety and Efficacy of BL-8040 for the Mobilization of Donor Hematopoietic Stem Cells and Allogeneic Transplantation in Patients With Advanced Hematological Malignancies
- Status
- COMPLETED
- Phase
- PHASE2
Study Evaluating the Safety and Pharmacokinetics of JCAR017 in B-cell Non-Hodgkin Lymphoma (TRANSCEND-NHL-001)
- Status
- COMPLETED
- Phase
- PHASE1
Study of Genistein in Pediatric Oncology Patients (UVA-Gen001)
- Status
- TERMINATED
- Phase
- PHASE2
Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer
- Status
- COMPLETED
- Phase
- PHASE1